Cytokinetics Announces Four Upcoming Presentations at the
SOUTH SAN FRANCISCO, Calif., March 25, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced four presentations at the...
Source: globenewswire.com
Obstructive Hypertrophic News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Obstructive Hypertrophic. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Obstructive Hypertrophic Today - Breaking & Trending Today
The Pathophysiology of Obstructive Hypertrophic Cardiomyopathy (oHCM)
Andrew Wang, MD, outlines the epidemiology of obstructive hypertrophic cardiomyopathy (oHCM), and Milind Desai, MD, MBA, reviews the etiology of the condition.
Source: hcplive.com
5 FDA Decisions to Watch for Through June 2023
From a novel topical gene therapy to a multi-pathway targeting HF drug, the second quarter of 2023 is laden with interesting regulatory decisions.
Source: hcplive.com
Cytokinetics Announces Upcoming Presentations at the 2022
Two Late Breaking Clinical Trials Sessions to Feature New Data from REDWOOD-HCM OLE...
Source: globenewswire.com
Experimental drug for hypertrophic cardiomyopathy reduces the need for invasive procedures, trial shows
Findings from a Cleveland Clinic-led clinical trial showed that the use of an experimental drug in severely symptomatic, hypertrophic cardiomyopathy patients significantly reduced the need for invasive procedures.
Source: news-medical.net